Stroke prevention in atrial fibrillation: focus on Asian patients

YG Li, SR Lee, EK Choi… - Korean circulation journal, 2018 - synapse.koreamed.org
Atrial fibrillation (AF) is the most common arrhythmia conferring a fivefold increased risk of
stroke. Stroke prevention is the cornerstone of management of patients with AF. Asians have …

[HTML][HTML] Prevention and treatment of atrial fibrillation via risk factor modification

EL O'Keefe, JE Sturgess, JH O'Keefe, S Gupta… - The American journal of …, 2021 - Elsevier
Atrial fibrillation (AF) is the most common clinically significant arrhythmia, and it increases
stroke risk. A preventive approach to AF is needed because virtually all treatments such as …

Stroke prevention in atrial fibrillation: State of the art

YG Li, GYH Lip - International journal of cardiology, 2019 - Elsevier
Stroke prevention is the cornerstone of the management of patients with atrial fibrillation
(AF). Individual stroke risk stratification is generally the first step of deciding whether oral …

Association of different oral anticoagulants use with renal function worsening in patients with atrial fibrillation: a multicentre cohort study

D Pastori, E Ettorre, GYH Lip… - British Journal of …, 2020 - Wiley Online Library
Aims To investigate the decline of estimated glomerular filtration rate (eGFR) in patients with
atrial fibrillation (AF) treated with vitamin K antagonists (VKAs) or non‐VKA oral …

One-year risks of stroke and mortality in patients with atrial fibrillation from different clinical settings: the Gulf SAFE registry and Darlington AF registry

YG Li, K Miyazawa, A Wolff, M Zubaid… - International Journal of …, 2019 - Elsevier
Background Differences exist in oral anticoagulation (OAC) use between different
populations with atrial fibrillation (AF), which may be associated with varying outcomes …

Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: biomarker substudy results from a prospective study with rivaroxaban (X-TRA)

K Miyazawa, D Pastori, C Hammerstingl… - Annals of …, 2018 - Taylor & Francis
Background: Non-vitamin K antagonist oral anticoagulants including rivaroxaban are widely
used for stroke prevention in patients with atrial fibrillation (AF). We investigated the …

[HTML][HTML] Significance of serum fibroblast growth factor-23 and miR-208b in pathogenesis of atrial fibrillation and their relationship with prognosis

JM Chen, YT Zhong, C Tu, J Lan - World Journal of Clinical Cases, 2020 - ncbi.nlm.nih.gov
BACKGROUND The incidence and prevalence of atrial fibrillation are increasing each year,
and this condition is one of the most common clinical arrhythmias. AIM To investigate the …

Tailored practical management of patients with atrial fibrillation: a risk factor-based approach

D Pastori, D Menichelli, R Gingis… - Frontiers in …, 2019 - frontiersin.org
The management of antithrombotic therapy for thromboprophylaxis in patients with atrial
fibrillation (AF) has been recently evolved by the progressive replacement of vitamin K …

Mitigation of stroke risk in nonvalvular atrial fibrillation patients with high-grade carotid artery stenosis

OMP Jolobe - The American journal of the medical sciences, 2018 - amjmedsci.com
Dear Editor, Notwithstanding the efficacy of the new oral anticoagulants (NOACs) in
mitigating the risk of systemic thromboembolism associated with nonvalvular atrial fibrillation …

[PDF][PDF] 心房颤动患者血清FGF-23, miR-208b 的表达水平及临床意义

张磊, 丁辉 - 海南医学, 2021 - hainanyixue.cn
目的探讨血清成纤维细胞生长因子23 (FGF23), miR-208b 在心房颤动患者中的表达水平及临床
意义. 方法选取2018 年5 月至2019 年10 月在西安市第三医院治疗的心房颤动患者240 …